» Articles » PMID: 32931633

Validation of a Description of Sarcopenic Obesity Defined As Excess Adiposity and Low Lean Mass Relative to Adiposity

Overview
Date 2020 Sep 15
PMID 32931633
Citations 12
Authors
Affiliations
Soon will be listed here.
Abstract

Background: This study aims to assess the construct validity of a body composition-defined definition of sarcopenic obesity based on low appendicular lean mass relative to fat mass (ALMI ) and high fat mass index (FMI) and to compare with an alternative definition using appendicular lean mass index (ALMI) and percent body fat (%BF).

Methods: This is a secondary analysis of two cohort studies: the National Health and Examination Survey (NHANES) and the Health, Aging, and Body Composition study (Health ABC). Sarcopenic obesity was defined as low ALMI combined with high FMI and was compared with a widely used definition based on ALMI and %BF cut-points. Body composition Z-scores, self-reported disability, physical functioning, and incident disability were compared across body composition categories using linear and logistic regression and Cox proportional hazards models.

Results: Among 14, 850 participants from NHANES, patients with sarcopenic obesity defined by low ALMI and high FMI (ALMI -FMI) had above-average FMI Z-scores [mean (standard deviation): 1.00 (0.72)]. In contrast, those with sarcopenic obesity based on low ALMI and high %BF (ALMI-%BF) had below-average FMI Z-scores. A similar pattern was observed for 2846 participants from Health ABC. Participants with sarcopenic obesity based on ALMI -FMI had a greater number of disabilities, worse physical function, and a greater risk of incident disability compared with those defined based on ALMI-%BF.

Conclusions: Body composition-defined measures of sarcopenic obesity defined as excess adiposity and lower-than-expected ALMI relative to FMI are associated with functional deficits and incident disability and overcome the limitations of using %BF in estimating obesity in this context.

Citing Articles

The agreement of low lean mass with obesity using different definitions and its correlation with hyperuricemia.

Xiao H, Hu L, Xie M, Du Y, Liao D Front Nutr. 2024; 11:1382254.

PMID: 38628269 PMC: 11019026. DOI: 10.3389/fnut.2024.1382254.


The causal relationship between sarcopenic obesity factors and benign prostate hyperplasia.

Rao X, Xu Z, Zhang J, Zhou J, Huang J, Toh Z Front Endocrinol (Lausanne). 2023; 14:1290639.

PMID: 38027182 PMC: 10663947. DOI: 10.3389/fendo.2023.1290639.


Sex- and reproductive status-specific relationships between body composition and non-alcoholic fatty liver disease.

Cao Y, Zhang W, Lou Y, Yan Q, Zhang Y, Qi F BMC Gastroenterol. 2023; 23(1):364.

PMID: 37875811 PMC: 10598923. DOI: 10.1186/s12876-023-02997-9.


Sex-Specific Impact of Body Weight on Atherosclerotic Cardiovascular Disease Incidence in Individuals With and Without Ideal Cardiovascular Health.

Paulin A, Manikpurage H, Despres J, Theriault S, Arsenault B J Am Heart Assoc. 2023; 12(13):e028502.

PMID: 37345817 PMC: 10356085. DOI: 10.1161/JAHA.122.028502.


The prevalence of low muscle mass associated with obesity in the USA.

Murdock D, Wu N, Grimsby J, Calle R, Donahue S, Glass D Skelet Muscle. 2022; 12(1):26.

PMID: 36539856 PMC: 9769063. DOI: 10.1186/s13395-022-00309-5.


References
1.
Sharma D, Hawkins M, Abramowitz M . Association of sarcopenia with eGFR and misclassification of obesity in adults with CKD in the United States. Clin J Am Soc Nephrol. 2014; 9(12):2079-88. PMC: 4255396. DOI: 10.2215/CJN.02140214. View

2.
Newman A, Kupelian V, Visser M, Simonsick E, Goodpaster B, Nevitt M . Sarcopenia: alternative definitions and associations with lower extremity function. J Am Geriatr Soc. 2003; 51(11):1602-9. DOI: 10.1046/j.1532-5415.2003.51534.x. View

3.
von Haehling S, Morley J, Coats A, Anker S . Ethical guidelines for publishing in the Journal of Cachexia, Sarcopenia and Muscle: update 2019. J Cachexia Sarcopenia Muscle. 2019; 10(5):1143-1145. PMC: 6818444. DOI: 10.1002/jcsm.12501. View

4.
Baker J, Harris T, Rapoport A, Ziolkowski S, Leonard M, Long J . Validation of a description of sarcopenic obesity defined as excess adiposity and low lean mass relative to adiposity. J Cachexia Sarcopenia Muscle. 2020; 11(6):1580-1589. PMC: 7749601. DOI: 10.1002/jcsm.12613. View

5.
Levine M, Crimmins E . The impact of insulin resistance and inflammation on the association between sarcopenic obesity and physical functioning. Obesity (Silver Spring). 2012; 20(10):2101-6. PMC: 3527629. DOI: 10.1038/oby.2012.20. View